Sort by 'listens'
Minimal Residual Disease with Dr. Guido Tricot
What is the difference, if there is one, between MRDzero and MRD negative? Do these definitions vary from institution to institution or are they standardized? The ultimate goal of treatment is to achieve MRDzero. If a patient does not achieve…
Myeloma with MD Anderson’s Dr. Orlowski
Shoot for a 100% complete response is what doctors are aiming for and this may soon become a reality with new drug combinations which are showing a lot of promise, informs Dr. Orlowksi. Newly diagnosed patients to high-risk patients, Dr.…
Using Clinical Data to Determine Treatments in Myeloma
Using Clinical Trial Data to Determine Treatment Options, has been successfully implemented by Dr. McCarthy and team and here he discusses the various preclinical new drug developments for myeloma treatment
Unraveling Castleman Disease
Dr. David Fajgenbaum was diagnosed with a rare disorder that killed 35% of patients within five years of diagnosis. Dr. Fajgenbaum realised that he would have to lead the charge against his rare condition and we are talking to this…
Dr. Larry Payne Discusses Yoga in Mid Life and Beyond
Dr. Larry Payne discusses importance of Yoga in Mid Life and Beyond. On the panel we have Dashama, Micheline Toussaint, Char Grossman and Marcela Clavijo.